Search research articles
Contact Us
Filters
Showing results (281-290 of 347) with videos related to
Page
of 35
Sort By:
Thoracic Cancer
|
May 17, 2022
Prevalence and management of pain in lung cancer patients in northern China: A multicenter cross-sectional study
Bo Zhang, Xingya Li, Zhiyong Ma, et al.
BMC Cancer
|
March 18, 2025
Telpegfilgrastim for chemotherapy-induced neutropenia in patients with non-small cell lung cancer: a multicentre, randomized, phase 3 study
Yuankai Shi, Xinshuai Wang, Zhidong Pei, et al.
Cancer Pathogenesis and Therapy
|
February 8, 2024
Clinical characteristics and treatment outcomes of Chinese diffuse large B-cell lymphoma patients in the era of rituximab (2005-2018)
Yuankai Shi, Haizhu Chen, Yan Qin, et al.
Haematologica
|
August 19, 2021
Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study
Lale Kostakoglu, Federico Mattiello, Maurizio Martelli, et al.
The Lancet. Respiratory Medicine
|
March 29, 2021
Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study
Yuankai Shi, Xingsheng Hu, Shucai Zhang, et al.
Cancer Biology & Medicine
|
February 16, 2019
Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment
Jing Wang, Yizhuo Zhao, Qiming Wang, et al.
Ebiomedicine
|
April 19, 2020
Circulating tumor DNA predicts response in Chinese patients with relapsed or refractory classical hodgkin lymphoma treated with sintilimab
Yuankai Shi, Hang Su, Yongping Song, et al.
Blood Advances
|
March 2, 2021
End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA
Lale Kostakoglu, Maurizio Martelli, Laurie H Sehn, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 20, 2019
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial
Yi-Long Wu, Shun Lu, Ying Cheng, et al.
Plos One
|
November 25, 2015
The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm, Multi-Center, Prospective Study
Xingsheng Hu, Li Zhang, Yuankai Shi, et al.
Page
of 35
Search research articles
Search
Showing results (281-290 of 347) with videos related to
Sort By:
Page
of 35
Thoracic Cancer
|
May 17, 2022
Prevalence and management of pain in lung cancer patients in northern China: A multicenter cross-sectional study
Bo Zhang, Xingya Li, Zhiyong Ma, et al.
BMC Cancer
|
March 18, 2025
Telpegfilgrastim for chemotherapy-induced neutropenia in patients with non-small cell lung cancer: a multicentre, randomized, phase 3 study
Yuankai Shi, Xinshuai Wang, Zhidong Pei, et al.
Cancer Pathogenesis and Therapy
|
February 8, 2024
Clinical characteristics and treatment outcomes of Chinese diffuse large B-cell lymphoma patients in the era of rituximab (2005-2018)
Yuankai Shi, Haizhu Chen, Yan Qin, et al.
Haematologica
|
August 19, 2021
Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study
Lale Kostakoglu, Federico Mattiello, Maurizio Martelli, et al.
The Lancet. Respiratory Medicine
|
March 29, 2021
Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study
Yuankai Shi, Xingsheng Hu, Shucai Zhang, et al.
Cancer Biology & Medicine
|
February 16, 2019
Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment
Jing Wang, Yizhuo Zhao, Qiming Wang, et al.
Ebiomedicine
|
April 19, 2020
Circulating tumor DNA predicts response in Chinese patients with relapsed or refractory classical hodgkin lymphoma treated with sintilimab
Yuankai Shi, Hang Su, Yongping Song, et al.
Blood Advances
|
March 2, 2021
End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA
Lale Kostakoglu, Maurizio Martelli, Laurie H Sehn, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 20, 2019
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial
Yi-Long Wu, Shun Lu, Ying Cheng, et al.
Plos One
|
November 25, 2015
The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm, Multi-Center, Prospective Study
Xingsheng Hu, Li Zhang, Yuankai Shi, et al.
Page
of 35